InvestorsHub Logo
Followers 276
Posts 36637
Boards Moderated 2
Alias Born 04/05/2012

Re: Golden Cross post# 1219

Friday, 09/30/2022 3:52:48 PM

Friday, September 30, 2022 3:52:48 PM

Post# of 1251
Topline data from the Phase 3 VIITAL™ study of EB-101 in RDEB is on track for late third quarter to early fourth quarter of 2022 upon completion of the last patient monitoring visit, which is expected by mid-September.

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABEO News